Lumos Pharma Inc (NASDAQ:LUMO)
| 3.54 Delayed Data As of Feb 03 |  +0.05 / +1.43%Today’s Change | 2.95 Today|||52-Week Range 10.27 | -1.94% Year-to-Date |
Latest LUMO News | Press Releases
No recent news for Lumos Pharma Inc.
Today’s Trading
| Previous close | 3.49 |
| Today’s open | 3.55 |
| Day’s range | 3.54 - 3.55 |
| Volume | 788 |
| Average volume (3 months) | 23,768 |
| Market cap | $29.8M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -291.92% |
| Earnings growth (this year) | -0.09% |
| Earnings growth (next 5 years) | +15.24% |
| Revenue growth (last year) | +36.90% |
| P/E ratio | NM |
| Price/Sales | 251.12 |
| Price/Book | 0.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LCILannett Company Inc | -0.02 | -2.65% |
| ---- | ||
| EDSAEdesa Biotech Inc | -0.06 | -3.87% |
| ZYNEZynerba Pharmaceutic... | +0.02 | +3.18% |
Data as of 3:57pm ET, 02/03/2023
Financials
| Next reporting date | March 8, 2023 |
| EPS forecast (this quarter) | -$0.93 |
| Annual revenue (last year) | $230.0K |
| Annual profit (last year) | -$30.4M |
| Net profit margin | -13,230.43% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
